Suchergebnisse - "Bréchot, Christian"

PubPharm (327)

1

Early treatment with nitazoxanide prevents worsening of mild and moderate COVID-19 and subsequent hospitalization

enthalten in: bioRxiv.org | 2024

von Rossignol, J. | Matthew, C. | Oaks, J. | +5

2

EU regulations for maximum containment labs

enthalten in: Science (New York, N.Y.) | 2024

von Brechot, C. | Szekely Björndal, �. | Ewbank, J.

3

HIP/PAP PROTEIN OR A DERIVATIVE THEREOF FOR TREATING PERIPHERAL NEUROPATHY

enthalten in: Europäisches Patentamt | 2024

von BRÉCHOT CHRISTIAN | AMOUYAL GILLES | AMOUYAL PAUL | +3

4

Nitazoxanide controls virus viability through its impact on membrane bioenergetics

enthalten in: ResearchSquare.com | 2024

von Hammad, N. | Ransy, C. | Pinson, B. | +4

5

Therapeutic vaccination with lentiviral vector in HBV-persistent mice and two inactive HBsAg carriers

enthalten in: Journal of hepatology | 2024

von Zhang, Y. | Bourgine, M. | Wan, Y. | +13

6

HIP/PAP PROTEIN OR DERIVATIVE THEREOF FOR THE TREATMENT OF PERIPHERAL

enthalten in: Europäisches Patentamt | 2024

von BRECHOT CHRISTIAN | AMOUYAL GILLES | AMOUYAL PAUL | +3

7

HIP/PAP PROTEIN OR A DERIVATIVE THEREOF FOR TREATING PERIPHERAL NEUROPATHY

enthalten in: Europäisches Patentamt | 2023

von BRÉCHOT CHRISTIAN | AMOUYAL GILLES | AMOUYAL PAUL | +3

8

HIP/PAP PROTEIN OR A DERIVATIVE THEREOF FOR TREATING PERIPHERAL NEUROPATHY

enthalten in: Europäisches Patentamt | 2023

von BRÉCHOT CHRISTIAN | AMOUYAL GILLES | AMOUYAL PAUL | +3

9

A mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut

enthalten in: Gut | 2023

von Mishra, S. | Wang, B. | Jain, S. | +8

CommentIn: Gut. 2023 Oct;72(10):1809-1811. - PMID 37105722

10

HIP/PAP PROTEIN OR A DERIVATIVE THEREOF FOR TREATING AND/OR PREVENTING A DISORDER CHARACTERIZED BY A HIGH CXCL5 LEVEL IN AN INDIVIDUAL

enthalten in: Europäisches Patentamt | 2023

von BRECHOT CHRISTIAN | AMOUYAL GILLES | AMOUYAL PAUL | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]